Table 1.
Patients features and outcomes
| Age (yr) | PRE-TEXT pre-QT | Segments involved at diagnosis | AFP at diagnosis (ng/mL) | Histology | Chemotherapy (No. of cycles) | POST-TEXT at surgery (localization) | Surgery | Postoperative events | Follow-up (mo) | Current status |
| 3 | III, P1 (right branch) | I, V, VI, VII, VIII | 18597.37 | Embryonal | Neoadjuvant PLA (4 cycles) + adjuvant (2c) | II (V, VI, VII, VIII) | Right hepatectomy | Subphrenic abscess (drainage) | 18 | CR |
| 4 | II, P1 (left branch) | IVb, V, VIII | 551.21 | Epithelial mesenchymal mixed | Neoadjuvant PLA (4c) + adjuvant (2c) | I (IVb) | Segmentectomy IVb | Uneventful | 19 | CR |
| 8 | I | II, III | 473856.00 | Epithelial fetal | Neoadjuvant PLADO (4c) + adjuv (2c) | I (II, III) | Left hepatectomy | Uneventful | 56 | CR |
| 13 | I | VIII | 14277.00 | Epithelial fetal | Neoadjuvant PLA (4c) + adjuv (2c) | I (VIII) | Right hepatectomy | Uneventful | 28 | CR |
| 15 | I | VI | 401800.00 | Epithelial mesenchymal mixed | Adjuvant PLADO (4c) | I (VI) | Tumorectomy | Uneventful | 106 | CR |
| 25 | II, P1 (right branch) | V, VI, VII, VIII | 83100.50 | Embryonal fetal epithelial | Neoadjuvant PLADO (4c) + adjuv (2c) | II, P0 (VII, VIII) | Bisegmentectomy VII, VIII | Uneventful | 13 | Lung metastasis |
| 31 | I | VI | 379.00 | Epithelial | Adjuvant PLADO (4c) | I (VI) | Segmentectomy VI | Uneventful | 50 | CR |
PLA: Cisplatin; DO: Doxorubicin; P1: Involvement of either the left or the right branch of the portal vein; CR: Complete remission.